Cem UZAL, Ercüment ÜNLÜ, Hakan KARAGÖL, Coşar Ruşen ALAS, Murat ÇALOĞLU, Yürüt Vuslet ÇALOĞLU, Zafer KOÇAK, Füsun TOKATLI

Bir olgu nedeniyle malign melanomlarda palyatif radyoterapi

Malign melanom oldukça kötü prognozlu bir cilt kanseri türüdür. Genel olarak radyorezistan olduğu düşünülmektedir. Günümüzde bu hastalığın tedavisinde sıklıkla hipofraksiyone radyoterapi şemaları kullanılmakla birlikte, standart tedavi şemasını belirleyebilecek literatür çalışmaları bulunmamaktadır. Bu yazıda, evre IV malign melanom tanılı, kanaması 5 fraksiyonda toplam 20 Gy eksternal radyoterapi ile etkin ve güvenli bir şekilde tedavi edilen bir olgu sunuldu.

Palliative radiotherapy for malign melanoma: a case report

Malignant melanoma is a skin cancer with poor prognosis. Historically melanoma has been thought of as a relatively radioresistant tumour. Nowadays, radiation delivered according to hypofractionated schedule is the most used, although there are few data confirm that this schedule improves the therapeutic impact. We report a case, with stage IV malignant melanoma, whose tumoral bleeding was palliated successfully giving 20 Gy external radiotherapy in 5 fractionations.

PDF

___

1) Apaydın F. Anatomik özellikler ve klinik gidiş. In: Esassolak M, editor. Baş-boyun kanserleri. İstanbul: Nobel Tıp Kitapevi; 2003. p. 605-19.
2) Bastiaannet E, Beukema JC, Hoekstra HJ. Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications. Cancer Treat Rev 2005;31(1):18-26.
3) Ang KK, Byers RM, Peters LJ, Maor MH, Wendt CD, Morrison WH, et al. Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Preliminary results. Arch Otolaryngol Head Neck Surg 1990;116(2):169 72.
4) Barranco SC, Romsdahl MM, Humphrey RM. The radiation response of human malignant melanoma cells grown in vitro. Cancer Res 1971;31(6):830-3.
5) Harwood AR. Conventional fractionated radiotherapy for 51 patients with lentigo maligna and lentigo maligna melanoma. Int J Radiat Oncol Biol Phys 1983;9(7):1019-21.
6) Habermalz HJ. Irradiation of malignant melanoma: experience in the past and present. Int J Radiat Oncol Biol Phys 1981;7(1):131-3.
7) Sause WT, Cooper JS, Rush S, Ago CT, Cosmatos D, Coughlin CT, et al. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys 1991;20(3):429-32.
8) Bentzen SM, Overgaard J, Thames HD, Overgaard M, Vejby Hansen P, von der Maase H, et al. Clinical radiobiology of malignant melanoma. Radiother Oncol 1989;16(3):169-82.
9) Trott KR. The optimal radiation dose per fraction for the treatment of malignant melanomas. Int J Radiat Oncol Biol Phys 1991;20(4):905-7.
10) Johanson CR, Harwood AR, Cummings BJ, Quirt I. 0- 7-21 radiotherapy in nodular melanoma. Cancer 1983;51(2):226-32.
11) Burmeister BH, Smithers BM, Poulsen M, McLeod GR, Bryant G, Tripcony L, et al. Radiation therapy for nodal disease in malignant melanoma. World J Surg 1995;19(3):369-71.
12) Overgaard J. The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study. Int J Radiat Oncol Biol Phys 1986;12:867-72.